Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Nuclear Medicine and Biology|November 17, 2001
Two routes to [11C-carbonyl]organo-isocyanates utilizing [11C]phosgene ([11C]organo-isocyanates from [11C]phosgene)G D Brown, D Henderson, C Steel, et al.European Journal of Cancer (Oxford, England : 1990)|November 18, 2005
Is the hypoxia-inducible factor pathway important in gastric cancer?E A Griffiths, S A Pritchard, I M Welch, et al.International Journal of Oncology|April 6, 2005
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sampleC S Brock, H Young, S Osman, et al.Journal of Virology|April 1, 1987
Murine cells carrying integrated tandem genomes of hepatitis B virus DNA transcribe RNAs from endogenous promoters on both viral strands and express middle and major viral envelope proteinsA Z Zelent, M A Sells, P M Price, et al.Microelectronics and Reliability|March 4, 2009
Impact of Single pMOSFET Dielectric Degradation on NAND Circuit PerformanceD Estrada, M L Ogas, R G Southwick, et al.Current Pharmaceutical Design|January 5, 2002
Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PETF Brady, S K Luthra, G D Brown, et al.NMR in Biomedicine|September 1, 1992
Positron emission tomography for tumour assessmentT Jones, D W Tilsley, C B Wilson, et al.Cancer Surveys|January 1, 1993
New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomographyD W Tilsley, R J Harte, T Jones, et al.The American Journal of Physiology|December 1, 1991
Expression of cytokine-like genes JE and KC is increased during renal ischemiaR Safirstein, J Megyesi, S J Saggi, et al.British Journal of Cancer|February 22, 2000
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomasC S Brock, H Young, S M O'Reilly, et al.Pageof 7